Pila Pharma AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	-16.86	-11.24	-9.93	-26.78	-17.21	Upgrade
Depreciation & Amortization	1.08	1.08	1.08	0.02	0.02	Upgrade
Other Operating Activities	6.2	3.08	3.5	17.89	7.92	Upgrade
Change in Accounts Receivable	-0.13	0.16	0.07	-0.06	-0.16	Upgrade
Change in Accounts Payable	-0.15	-0.79	0.82	-0	0.14	Upgrade
Change in Other Net Operating Assets	0.68	-0.11	-0.39	-0.16	-0.07	Upgrade
Operating Cash Flow	-9.19	-7.82	-4.85	-9.09	-9.36	Upgrade
Long-Term Debt Issued	-	-	1.5	-	-	Upgrade
Total Debt Issued	-	-	1.5	-	-	Upgrade
Short-Term Debt Repaid	-	-	-	-	-0.5	Upgrade
Long-Term Debt Repaid	-	-	-1.5	-	-	Upgrade
Total Debt Repaid	-	-	-1.5	-	-0.5	Upgrade
Net Debt Issued (Repaid)	-	-	-	-	-0.5	Upgrade
Issuance of Common Stock	32.47	10	7.06	6.92	48.54	Upgrade
Other Financing Activities	-12.28	-3.24	-3.5	-18.8	-12.37	Upgrade
Financing Cash Flow	20.19	6.76	3.56	-11.88	35.67	Upgrade
Net Cash Flow	11.01	-1.06	-1.29	-20.97	26.3	Upgrade
Levered Free Cash Flow	-3.66	-4.66	-2.44	-5.76	-5.88	Upgrade
Unlevered Free Cash Flow	-3.52	-4.66	-2.42	-5.76	-5.86	Upgrade
Change in Working Capital	0.4	-0.74	0.5	-0.22	-0.09	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.